Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone to Improve Oxygenation in Brain-Dead Organ Donors
NCT02581111Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of naloxone in brain death, hypoxemia, sponsored by Washington University School of Medicine. Started Sep 2015; status: completed.
02
Drugs
naloxone
03
Conditions
brain deathhypoxemia
Beyond the preview
Go deeper on NCT02581111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02581111.